De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
EQS Overzicht aandelen
Equasens Société anonyme levert IT-oplossingen voor de gezondheidszorg in Europa.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 4/6 |
Beloningen
Risicoanalyse
Geen risico's gedetecteerd voor EQS uit onze risicocontroles.
Equasens Société anonyme Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | €50.40 |
| 52 Week Hoogtepunt | €73.90 |
| 52 Week Laag | €42.95 |
| Bèta | 0.91 |
| 11 maand verandering | 5.66% |
| 3 maanden verandering | -3.08% |
| 1 Jaar Verandering | -30.77% |
| 33 jaar verandering | -47.83% |
| 5 jaar verandering | -13.10% |
| Verandering sinds IPO | 1,083.10% |
Recent nieuws en updates
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28
Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Recent updates
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Jun 07Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?
Dec 01Rendement voor aandeelhouders
| EQS | FR Healthcare Services | FR Markt | |
|---|---|---|---|
| 7D | 5.5% | 2.7% | 0.9% |
| 1Y | -30.8% | 18.5% | 5.0% |
Rendement versus industrie: EQS presteerde slechter dan de French Healthcare Services -sector, die het afgelopen jaar een rendement van 18.5 % opleverde.
Rendement versus markt: EQS presteerde slechter dan French Market, dat het afgelopen jaar een rendement van 5 % opleverde.
Prijsvolatiliteit
| EQS volatility | |
|---|---|
| EQS Average Weekly Movement | 5.7% |
| Healthcare Services Industry Average Movement | 5.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in FR Market | 9.6% |
| 10% least volatile stocks in FR Market | 2.2% |
Stabiele aandelenkoers: EQS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van EQS is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1996 | 1,271 | Denis Supplisson | equasens.com |
Equasens Société anonyme levert IT-oplossingen voor de gezondheidszorg in Europa. Het biedt id. PATIENT, een zakelijke software; id.
Equasens Société anonyme Samenvatting
| EQS fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €757.57m |
| Inkomsten(TTM) | €47.05m |
| Inkomsten(TTM) | €219.79m |
16.1x
Koers/Winstverhouding3.4x
P/S-verhoudingIs EQS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| EQS resultatenrekening (TTM) | |
|---|---|
| Inkomsten | €219.79m |
| Kosten van inkomsten | €149.91m |
| Brutowinst | €69.88m |
| Overige uitgaven | €22.83m |
| Inkomsten | €47.05m |
Laatst gerapporteerde inkomsten
Dec 31, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 3.13 |
| Brutomarge | 31.79% |
| Nettowinstmarge | 21.41% |
| Schuld/Eigen Vermogen Verhouding | 25.7% |
Hoe presteerde EQS op de lange termijn?
Bekijk historische prestaties en vergelijking